Articles
At the Association of Community Cancer Centers 49th Annual Meeting & Cancer Business Summit, Andre Harvin, PharmD, MS, MBA, Executive Director of Pharmacy, Oncology Services, Cone Health Cancer Center, Greensboro, NC, presented a keynote lecture titled, “Robots, Biologics, and Advocates: Lessons from the Pharmacy.” Read More ›
An interview with Andre Harvin, PharmD, MS, MBA
On June 20, 2023, the FDA approved a new indication for talazoparib, an oral poly (ADP-ribose) polymerase inhibitor, in combination with enzalutamide for homologous recombination repair gene mutation–positive, metastatic castration-resistant prostate cancer. Read More ›
Health insurance coverage mediated racial and ethnic inequities among patients with advanced-stage cervical cancer, according to findings from a recent retrospective, cross-sectional, population-based study. Read More ›
Sarcoma is a general term used to describe a broad group of rare malignancies that develop in the body’s bone and connective tissue, such as fat, muscle, nerves, blood vessels, and the tissue that surrounds bones and joints. It is frequently referred to as the “forgotten cancer” because it comprises a very small percentage of all adult cancers. Read More ›
A new study has found that partners of colorectal cancer survivors experienced long-term financial toxicity that was associated with worse health-related quality of life due to systems- and individual-level behavioral factors. Read More ›
Biomarker testing is a necessary tool in the advancing world of precision cancer treatment. Read More ›
During the 2023 American Association for Cancer Research Annual Meeting, researchers presented results from a phase 2b clinical trial demonstrating significant improvement in recurrence-free survival in patients with high-risk melanoma who were treated with a combination of an investigational personalized mRNA-based vaccine plus the immune checkpoint inhibitor pembrolizumab (Keytruda), compared with pembrolizumab alone. Read More ›
The May issue of The Oncology Pharmacist contains valuable news and updates for today’s oncology pharmacist, including the latest data from clinical trials evaluating the safety and efficacy of novel therapies being used to treat a variety of cancers; highlights from the recent National Comprehensive Cancer Network Annual Conference; key takeaways from a survey documenting the ways in which inflation is affecting how consumers make decisions regarding their healthcare; and details on an innovative program being offered by the American Society of Health-System Pharmacists with the goal of helping pharmacists combat burnout in the workplace. Read More ›
Vaccination against human papillomavirus can prevent several types of cancer, including cervical, oral/oropharyngeal, penile, and anal cancers. Read More ›
The consumption of ultra-processed foods is associated with an increased risk for cancer and cancer-related death, according to findings from a recent study. Read More ›